Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study

Critical Care Medicine

Volumn 26, Issue 11, 1998, Pages 1793-1800

  Vincent, Jean Louis ^a   De Mendonça, Arnaldo ^a   Cantraine, Francis ^a   Moreno, Rui ^a   Takala, Jukka ^a   Suter, Peter M ^a   Sprung, Charles L ^a   Colardyn, Francis ^a   Blecher, Serge ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Circulatory failure; Circulatory shock; Coagulation abnormalities; Critically ill; Hepatic failure; Intensive care; Morbidity; Neurologic dysfunction; Organ failure; Outcome; Renal failure; Respiratory failure

Indexed keywords

ADULT; AGED; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; FEMALE; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY FAILURE; LENGTH OF STAY; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; NEUROLOGIC DISEASE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; REVIEW; SCORING SYSTEM; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031735051     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199811000-00016     Document Type: Review

References (5)

1. McCloskey RV, Straube RC, Sanders C, et al: Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1994; 121:1-5
2. Dhainaut JF, Tenaillon A, Le Tulzo Y, et al: Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group. Crit Care Med 1994; 22:1720-1728
3. Fisher CJ Jr, Agosti JM, Opal SM, et al: Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. N Engl J Med 1996; 334:1697-1702
4. Cohen J, Carlet J, INTERSEPT Study Group. INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-a in patients with sepsis. Crit Care Med 1996; 24:1431-1440
5. Fisher CJ, Dhainaut JF, Opal SM, et al: Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. JAMA 1994; 271:1836-1843